Research suggests no substantive outcome differences between the use of originator biologics and their biosimilar counterparts Source: Shutterstock.com
Caution is required when prescribing or dispensing long-acting beta agonists to manage airways diseases, such as asthma.
Since the dawn of hormonal replacement therapy — now known as menopausal hormone therapy — there have been conflicting reports about its risks and safety. A thorough examination of the evidence suggests it can be used safely in menopausal women.
Approval of the first over-the-counter topical retinoid in the United States is a welcome move and should be replicated in other countries.
Removing official pain measures will not alleviate the rising number of patients addicted to opioid drugs — a better way to determine pain is required.